Skip to main content

Articles

Page 2 of 18

  1. Long-acting injectable formulations for HIV infection have been approved and are now available in Japan. Although not currently recommended as first-line drugs in Japanese or overseas guidelines, use of such f...

    Authors: Masashi Ishihara, Shinichi Hikasa, Mariko Tsukiji, Yusuke Kunimoto, Kazuko Nobori, Takeshi Kimura, Kenta Onishi, Yuki Yamamoto, Kyohei Haruta, Yohei Kashiwabara, Kenji Fujii, Shota Shimabukuro, Daichi Watanabe, Hisashi Tsurumi and Akio Suzuki
    Citation: AIDS Research and Therapy 2023 20:62
  2. Managing multidrug-resistant (MDR) HIV infections in children is particularly challenging due to the lack of experience with new drugs in the pediatric setting. Second-line albuvirtide (ABT) with an optimized ...

    Authors: Wei Tang, Xiao-yun Song, Jing Cao, Chun Liu and Fang Zheng
    Citation: AIDS Research and Therapy 2023 20:60
  3. Low health literacy (HL) among people living with HIV (PLWHIV) encounter more disease related complications, more difficulty understanding health-related information and low adherence. Considering that, the HL...

    Authors: Lotte Ørneborg Rodkjaer, Merete Storgaard, Nanna Toxvig Sørensen and Liv Marit Valen Schougaard
    Citation: AIDS Research and Therapy 2023 20:59
  4. The increased survival provided by the access, development, and evolution of antiretroviral drugs (ARV) greatly increased the life expectancy of people living with HIV (PWH). This has also led to an increased ...

    Authors: Robson Pierre Nascimento da Silva, Luana M. S. Marins, Lusiele Guaraldo, Paula Mendes Luz, Sandra W. Cardoso, Ronaldo I. Moreira, Vanessa da Gama Oliveira, Valdilea G. Veloso, Beatriz Grinsztejn, Rita Estrela and Thiago S. Torres
    Citation: AIDS Research and Therapy 2023 20:57
  5. HIV infection increases the risk of type 2 diabetes and may influence its phenotypic profile. In this study, we aimed to compare the anthropometric and metabolic characteristics of HIV-infected and uninfected ...

    Authors: Davis Kibirige, Isaac Sekitoleko, Noela Owarwo, Irene Andia-Biraro and William Lumu
    Citation: AIDS Research and Therapy 2023 20:56
  6. Antiretroviral therapy (ART) has led to a decline in human immunodeficiency virus (HIV)-related mortality, but comorbidities, including organ dysfunction, are increasingly the focus of care. Heart transplant (...

    Authors: Thamer A. Almangour, Preston T. Skersick, Amanda Corbett, Jo E. Rodgers, Patricia P. Chang and Claire E. Farel
    Citation: AIDS Research and Therapy 2023 20:55
  7. South Africa is reported to have the highest burden of HIV with an estimated 8.2 million people living with HIV (PLHIV) in 2021- despite adopting the World Health Organisation (WHO) universal HIV test and trea...

    Authors: Abenathi Mcinziba, Peter Bock, Graeme Hoddinott, Janet Seeley, Virginia Bond, Sarah Fidler and Lario Viljoen
    Citation: AIDS Research and Therapy 2023 20:54
  8. Varicella-Zoster virus (VZV) vasculopathy occasionally occurs in immunocompromised patients and is difficult to treat. The risk factor and optimal therapy remain unclear. Patients with human immunodeficiency v...

    Authors: Kazuhiro Ishikawa, Fujimi Kawai and Nobuyoshi Mori
    Citation: AIDS Research and Therapy 2023 20:53
  9. Intimate partner violence is the most pervasive but less recognized problem which affects millions of women world. It is more common among marginalized individuals including women affected by HIV. However, the...

    Authors: Shibiru Biranu, Motuma Getachew, Gemechu Kejela and Chaltu Kifilu
    Citation: AIDS Research and Therapy 2023 20:52
  10. MSM are at high risk of HIV infection. Previous studies have shown that the cell cycle regulation plays an important role in HIV-1 infection, especially at the G2/M checkpoint. ATR, Chk1, Cdc25C and CDK1 are key ...

    Authors: Jiawei Wu, Lidan Xu, Bangquan Liu, Wenjing Sun, Yuanting Hu, Yi Yang, Keer Guo, Xueyuan Jia, Haiming Sun, Jie Wu, Yun Huang, Wei Ji, Songbin Fu, Yuandong Qiao and Xuelong Zhang
    Citation: AIDS Research and Therapy 2023 20:51
  11. Human immunodeficiency virus (HIV) has a protean clinical picture, in rare instances manifesting as systemic autoimmune disorders such as vasculitides. HIV-induced autoimmune diseases often do not respond well...

    Authors: Alice Bartoletti, Paolo Delvino, Marco Minetto, Alessandra Milanesi, Emanuele Bozzalla Cassione, Verdiana Serena Quadrelli, Ombretta Luinetti, Sara Monti and Carlomaurizio Montecucco
    Citation: AIDS Research and Therapy 2023 20:50
  12. Kidney disease is an important comorbidity in people living with HIV(PLWH), and is associated with poor outcomes. However, data on renal function of PLWH are limited in China so far. In this study we assessed ...

    Authors: Naxin Zhao, Pan Xiang, Zhili Zeng, Hongyuan Liang, Fang Wang, Jiang Xiao, Di Yang, Sa Wang, Meiling Chen and Guiju Gao
    Citation: AIDS Research and Therapy 2023 20:49
  13. Actinomycosis is an unusual chronic bacterial infection, even rarer in people living with HIV. It is not considered an AIDS-defining disease. However, the role in co-presentation or overlap with other opportun...

    Authors: Elsa K. Vargas-Garcia, Augusto R. Fernandez-Aristi, Gonzalo Cornejo-Venegas, Juan José Montenegro-Idrogo, Juan Chirinos-Vega and Alfredo Chiappe-Gonzalez
    Citation: AIDS Research and Therapy 2023 20:48
  14. Understanding context-specific determinants of antiretroviral therapy (ART) adherence is crucial for developing tailored interventions for improving health outcomes and achieving the UNAIDS’ third 95% target. ...

    Authors: Sovannary Tuot, Jian Wei Sim, Michiko Nagashima-Hayashi, Pheak Chhoun, Alvin Kuo Jing Teo, Kiesha Prem and Siyan Yi
    Citation: AIDS Research and Therapy 2023 20:47
  15. To compare the efficacy and injection frequency of intravitreal low-dose vs. intermediate-dose ganciclovir therapy in acquired immune deficiency syndrome (AIDS) patients exhibiting cytomegalovirus retinitis (C...

    Authors: Xuemei Liang, Hongmei An, Huawei He, Baiyun Shen, Zuguo Ou and Li Li
    Citation: AIDS Research and Therapy 2023 20:46
  16. HIV prevalence in Tanzania is still high at 4.7% among adults. Regular HIV testing is consistently advocated in the country to increase the level of awareness of HIV status, thus contributing to national HIV p...

    Authors: Ramadhani Abdul, Tobias F. Rinke de Wit, Giulia Martelli, Kathleen Costigan, Patrobas Katambi, Peter Mllacha, Anton Pozniak, Werner Maokola, Sayoki Mfinanga and Sabine Hermans
    Citation: AIDS Research and Therapy 2023 20:44
  17. Pre-Exposure Prophylaxis (PrEP) has demonstrated clinical efficacy in preventing HIV infection, yet its uptake remains low. This study, conducted in five PrEP implementing districts in Lesotho, examined factor...

    Authors: Joy J. Chebet, Shannon A. McMahon, Tapiwa Tarumbiswa, Hlalele Hlalele, Chivimbiso Maponga, Esther Mandara, Kacey Ernst, Halimatou Alaofe, Till Baernighausen, John E. Ehiri, Pascal Geldsetzer and Mark Nichter
    Citation: AIDS Research and Therapy 2023 20:43
  18. Poor adherence and under-utilization of antiretroviral therapy (ART) services have been major setbacks to achieving 95-95-95 policy goals in Sub-Saharan Africa. Social support and mental health challenges may ...

    Authors: Jerry John Nutor, Akua O. Gyamerah, Robert Kaba Alhassan, Henry Ofori Duah, Rachel G.A. Thompson, Natalie Wilson, Orlando Harris, Jose Gutierrez, Thomas J. Hoffmann, Monica Getahun and Glenn-Milo Santos
    Citation: AIDS Research and Therapy 2023 20:42
  19. This retrospective study aimed to characterize the distribution of HIV-1 genotypes and the prevalence of drug resistance mutations in people with antiretroviral treatment (ART) failure in Suzhou City, China.

    Authors: Zefeng Dong, Zhihui Xu, Ying Zhou, Runfang Tian, Kai Zhou, Di Wang, Xuerong Ya and Qiang Shen
    Citation: AIDS Research and Therapy 2023 20:41
  20. Within the African region, there are an estimated 8 million people living with HIV (PLHIV) in South Africa. Seeking healthcare services from traditional healers (TH) is one of the alternative and complementary...

    Authors: Joshua Okyere, Castro Ayebeng, Bernard Afriyie Owusu, Wonder Agbemavi, Joseph Kwarteng Amoako and Kwamena Sekyi Dickson
    Citation: AIDS Research and Therapy 2023 20:40
  21. In 2016 the WHO declared HIV self-testing and self-sampling an effective and safe test option that can reduce testing barriers. HIV self-tests and self-sampling kits (HIVST/HIVSS) are available for purchase at...

    Authors: Chaima Kandil, Jacqueline Hugtenburg, Titia Heijman, Hanna Bos, Martina Teichert, Renee Finkenflügel and Eline Op de Coul
    Citation: AIDS Research and Therapy 2023 20:39
  22. The patients’ perception of the health service is a vital tool for measuring health service quality. Besides, Patient satisfaction is an essential feature in assessing the quality of health services. Health in...

    Authors: Tafere Mulaw Belete, Solomon Asmamaw Tadesse, Kidist Atnafu, Minilik Kelemu and Assefa Belay Asrie
    Citation: AIDS Research and Therapy 2023 20:38
  23. Antiretroviral therapy (ART) is very effective in preventing vertical transmission of HIV but some women on ART experience different virologic, immunologic, and safety profiles. While most pregnant women are c...

    Authors: Maganizo B. Chagomerana, Bryna J. Harrington, Bethany L. DiPrete, Shaphil Wallie, Madalitso Maliwichi, Austin Wesevich, Jacob N. Phulusa, Wiza Kumwenda, Allan Jumbe and Mina C. Hosseinipour
    Citation: AIDS Research and Therapy 2023 20:37
  24. Concerns about the interconnected relationship between HIV and mental health were heightened during the COVID-19 pandemic. This study assessed whether there were temporal changes in the mental health status of...

    Authors: Solis Winters, Amon Sabasaba, Carolyn A. Fahey, Laura Packel, Emmanuel Katabaro, Yudas Ndungile, Prosper F. Njau and Sandra I. McCoy
    Citation: AIDS Research and Therapy 2023 20:36
  25. Effective antiretroviral therapy (ART) in people living with HIV (PLWH) has improved life expectancy and increased risk of age-associated cardiometabolic comorbidities. At-risk alcohol use is more frequent amo...

    Authors: Liz Simon, Stefany D. Primeaux, Danielle E. Levitt, Brianna Bourgeois, Neil M. Johannsen, Adrianna Peters, Jameel Ahmed, Richard H. Marshall, Alexandra H. Fairchild, Tekeda F. Ferguson and Patricia E. Molina
    Citation: AIDS Research and Therapy 2023 20:35
  26. The mental health and medical follow-up of people living with HIV (PLWH) have been disrupted by the COVID-19 pandemic. The objectives of this study were to assess anxiety, depression and substance use in Mexic...

    Authors: Ester Gutiérrez-Velilla, Vania Barrientos-Casarrubias, María Gómez-Palacio Schjetnan, Lydia E. Perrusquia-Ortiz, Rosa Cruz-Maycott, Claudia Alvarado-de la Barrera, Santiago Ávila-Ríos and Nancy Patricia Caballero-Suárez
    Citation: AIDS Research and Therapy 2023 20:34
  27. Discrete choice experiments (DCEs) are used to assess the strength of preferences and value of interventions. However, researchers using this approach have been criticized for not conducting or publishing rigo...

    Authors: Yihalem Abebe Belay, Mezgebu Yitayal, Asmamaw Atnafu and Fitalew Agimass Taye
    Citation: AIDS Research and Therapy 2023 20:33
  28. Pre-exposure prophylaxis (PrEP) is a proven biomedical strategy to prevent HIV transmission among men who have sex with men (MSM). Despite oral PrEP is safe and effective in MSM, the use of PrEP has been disco...

    Authors: Guang Zhang, Xue Yang, Wenting Kang, Tongtong Liu, Lili Cheng, Meixia Qu, Xinlun Wang and Houlin Tang
    Citation: AIDS Research and Therapy 2023 20:32
  29. Homosexual contact is the main route of human immunodeficiency virus type one (HIV-1) transmission in Cangzhou Prefecture, Hebei, China. Moreover, the number of circulating recombinant forms (CRFs) and unique ...

    Authors: Xinli Lu, Wenbin Gao, Yingying Wang, Meng Liu, Ning An, Yan Li, Yuqi Zhang and Qi Li
    Citation: AIDS Research and Therapy 2023 20:31
  30. Gut damage allows translocation of bacterial lipopolysaccharide (LPS) and fungal β-D-glucan (BDG) into the blood. This microbial translocation contributes to systemic inflammation and risk of non-AIDS comorbid...

    Authors: Stéphane Isnard, Léna Royston, Susan C. Scott, Tsoarello Mabanga, John Lin, Brandon Fombuena, Simeng Bu, Carolina A. Berini, Mark S. Goldberg, Malcolm Finkelman, Marie-Josée Brouillette, Lesley K. Fellows, Nancy E. Mayo and Jean-Pierre Routy
    Citation: AIDS Research and Therapy 2023 20:30
  31. Polypharmacy, using five or more medications, may increase the risk of nonadherence to prescribed treatment. We aimed to identify the interrelationship between trajectories of adherence to antiretroviral thera...

    Authors: Abubaker Ibrahim Elbur, Musie Ghebremichael, Deborah Konkle-Parker, Deborah L Jones, Shelby Collins, Adaora A. Adimora, Michael F. Schneider, Mardge H. Cohen, Bani Tamraz, Michael Plankey, Tracey Wilson, Adebola Adedimeji, Jessica E. Haberer and Denise L. Jacobson
    Citation: AIDS Research and Therapy 2023 20:29
  32. Immune reconstitution inflammatory syndrome (IRIS) associated with syphilis has rarely been described in HIV-infected patients. Diagnosis can be challenging because it is not always possible to discern it from...

    Authors: Luca Pipitò, Alice Annalisa Medaglia, Marcello Trizzino, Silvia Bonura, Claudia Gioè, Paola Di Carlo, Claudia Colomba and Antonio Cascio
    Citation: AIDS Research and Therapy 2023 20:28
  33. COVID-19 has not only taken a staggering toll in terms of cases and lives lost, but also in its psychosocial effects. We assessed the psychosocial impacts of the COVID-19 pandemic in a large cohort of people w...

    Authors: Anne K. Monroe, Paige E. Kulie, Morgan E. Byrne, Brittany C. Wilbourn, Shannon K. Barth, Jenna B. Resnik, David M. Huebner, Michael A. Horberg, Amanda D. Castel and Alan E. Greenberg
    Citation: AIDS Research and Therapy 2023 20:27
  34. Prolonged exposure to HIV and anti-retroviral therapy (ART) has been linked with endothelial cell activation which subsequently predisposes people living with HIV (PLWH) to cardiovascular diseases. Serum bioma...

    Authors: Andrew Weil Semulimi, Charles Batte, Alice Bayiyana, Mariam Nakabuye, John Mukisa, Barbara Castelnuovo, Rosalind Parkes Ratanshi, Bruce J Kirenga and Isaac Ssinabulya
    Citation: AIDS Research and Therapy 2023 20:26
  35. Behavioral economic (BE) biases have been studied in the context of numerous health conditions, yet are understudied in the field of HIV prevention. This aim of this study was to quantify the prevalence of fou...

    Authors: Larissa Jennings Mayo-Wilson, Jessica Coleman Lewis, Sarah MacCarthy and Sebastian Linnemayr
    Citation: AIDS Research and Therapy 2023 20:25
  36. Expanding pre-exposure prophylaxis (PrEP) among transgender women in the United States is an important strategy to meet national HIV prevention goals, however self-reported use of PrEP is low in this group.

    Authors: Lisa M. Kuhns, Judy Perloff, Amy K. Johnson, Josie Lynne Paul, Kevin Pleasant, Kaiji Evans, Damian J. Denson, Deborah J. Gelaude, Patricia A. Bessler, Rose Diskin, Marbella Cervantes, Robert Garofalo and Anna L. Hotton
    Citation: AIDS Research and Therapy 2023 20:24
  37. Despite substantial antiretroviral therapy (ART) coverage among individuals with human immunodeficiency virus (HIV) infection in Tanzania, viral load suppression (VLS) among HIV-positive children receiving ART...

    Authors: Kihulya Mageda, Khamis Kulemba, Wilhelmina Olomi, Ntuli Kapologwe, Leornad Katalambula and Pammla Petrucka
    Citation: AIDS Research and Therapy 2023 20:22
  38. Women who are newly diagnosed with HIV infection during pregnancy may not be ready to immediately initiate lifelong antiretroviral therapy (ART; called Option B +) as is recommended. Lack of “readiness” drives...

    Authors: Mwangelwa Mubiana-Mbewe, Samuel Bosomprah, Rakesh Kumar Saroj, Jillian Kadota, Aybuke Koyuncu, Kusanthan Thankian and Michael J. Vinikoor
    Citation: AIDS Research and Therapy 2023 20:21
  39. We investigated the association between CYP2B6 polymorphisms and efavirenz drug resistance among women living with HIV who started on antiretroviral therapy during pregnancy and with high viremia during post-part...

    Authors: Allan Buzibye, Kara Wools-Kaloustian, Adeniyi Olagunju, Ellon Twinomuhwezi, Constantin Yiannoutsos, Andrew Owen, Megan Neary, Joshua Matovu, Grace Banturaki, Barbara Castelnuovo, Mohammed Lamorde, Saye Khoo, Catriona Waitt and Agnes Kiragga
    Citation: AIDS Research and Therapy 2023 20:20
  40. Interruption in Treatment (IIT) is a challenge in HIV care and treatment programs in sub- Saharan Africa. High IIT among HIV adolescents has both individual and potential public health consequences including d...

    Authors: Expeditho L. Mtisi, Stella E. Mushy, Simon G. Mkawe, Antony Ndjovu, Eric Mboggo, Boniface S. Mlay, Frida Ngalesoni and Aisa Muya
    Citation: AIDS Research and Therapy 2023 20:19
  41. The Joint United Nations Programme on HIV/AIDS through the 95-95-95 target requires 95% of people living with HIV (PLHIV) on antiretroviral treatment (ART) to be virally suppressed. Viral Load (VL) non-suppres...

    Authors: Catherine Nakaye, Nelson Mukiza, Denis Mawanda, Hajira Kataike, Hellen Kaganzi, Grace Miriam Ahimbisibwe, Gerald Bright Businge, Raymonds Crespo Kyambadde and Rita Nakalega
    Citation: AIDS Research and Therapy 2023 20:18
  42. The long-term efficacy and safety of the 2-drug regimen dolutegravir (DTG) + lamivudine (3TC) and 3-drug single-tablet regimens recommended for antiretroviral therapy (ART)-naive people with HIV-1 (PWH) have y...

    Authors: Lee A. Evitt, Sakina Nanji, Richard A. Grove, Chinyere Okoli, Jean van Wyk and Sonya J. Snedecor
    Citation: AIDS Research and Therapy 2023 20:17
  43. The usage of antiretroviral treatment (ART) has considerably decreased the morbidity and mortality related to HIV-1 (human immunodeficiency virus type 1) infection. However, ART is ineffective in eradicating t...

    Authors: Ruojing Bai, Chengcheng Song, Shiyun Lv, Linlin Chang, Wei Hua, Wenjia Weng, Hao Wu and Lili Dai
    Citation: AIDS Research and Therapy 2023 20:16
  44. Following reports of anti-retroviral therapy (ART) experienced Ugandan people living with HIV (PLHIV) presenting with diabetic ketoacidosis weeks to months following a switch to dolutegravir (DTG), the Uganda ...

    Authors: Frank Mulindwa, Barbara Castelnuovo, Nele Brusselaers, Robert Bollinger, Joshua Rhein, Mutebi Edrisa, Allan Buzibye, Willington Amutuhaire, George Yendewa, Sarah Nabaggala, Eva Laker Agnes Odongpiny, Ronald Kiguba, Aisha Nakawooza, Simon Dujanga, Martin Nabwana and Jean-Marc Schwarz
    Citation: AIDS Research and Therapy 2023 20:15
  45. HIV status disclosure among sexual partners is vital in HIV management. Community health workers (CHW) support HIV disclosure among adults living with HIV (ALHIV) in sexual relationships with disclosure diffic...

    Authors: Zubair Lukyamuzi, Bashir Ssuna, Ruth Nabisere Mirembe, Denis Mawanda, Paul Kinkumu, Christine Nalugo, Esther Adikin, Faridah Namisango, Rita Nakalega, Patience Atuhaire, Philippa Musoke and Lisa M. Butler
    Citation: AIDS Research and Therapy 2023 20:14
  46. Chronic inflammation has been described in people living with HIV (PLHIV) receiving antiretroviral therapy (ART) despite viral suppression. Inflammation associated non-communicable diseases, including atherosc...

    Authors: Sirawat Srichatrapimuk, Artit Wongsa, Somnuek Sungkanuparph, Sasisopin Kiertiburanakul, Boonrat Tassaneetrithep and Angsana Phuphuakrat
    Citation: AIDS Research and Therapy 2023 20:13